Second GTL project gets green light

• Publisher: Elsevier Science
• Year: 2004
• Weight: 61 KB
• Volume: 2004
• Category: Article
• ISSN: 1351-4180
• DOI: 10.1016/s1351-4180(04)00239-9

✦ Synopsis

Around 38% of PTC's business is to the drugs industry. PTC says it has been getting many inquiries from generic drug producers. The company's technology can help save money by increasing yield, cutting cycle time, replacing expensive hazardous strong bases with cheaper organic bases, and reducing excessive reactant use. PTC has benefited from the tough economic climate, as manufacturers seek ways to cut costs.